Compare Blue Owl Capital Inc. Class A Common Stock (OWL) vs Ulta Beauty Inc (ULTA) Price & Performance

Blue Owl Capital (OWL) trades at $9.29, down 0.54% on the day, with neutral technical indicators showing support at $9 and resistance at $10. The company reported mixed quarterly earnings, beating expectations in Q4 2025 and Q2 2026 but missing in Q1 2026, with Q3 2026 results pending. Revenue growth remains steady at $2.9B in 2025, projected to $3.0B in 2026, though net margins are thin at 2.71%. Analyst sentiment is positive with 63% buy ratings and a $11.01 consensus target, but private credit fund redemptions and loan quality concerns present headwinds.

OWL offers value at a discount to analyst targets with strong institutional backing, but investors face risks from high P/E valuation (77.42), exposure to private credit volatility, and competitive pressures. The stock's 9.8% dividend yield and embedded fee growth from $31.1B in committed capital support upside, though execution on portfolio quality and redemption management will dictate near-term performance. Neutral outlook with cautious optimism pending Q3 earnings clarity.

ULTA stock trades at $592.42, up 4.4% on the day, reflecting strong momentum after recent earnings beats and raised guidance. The technical outlook is bullish, with the current price near resistance at $589. Fundamentally, the company shows robust profitability with a 9.34% net margin and 46.12% ROE, though revenue growth has moderated. Analyst sentiment remains positive with a consensus price target of $624.93 and 60% buy ratings, supported by e-commerce strength and expansion into wellness categories.

The outlook for ULTA is favorable, driven by e-commerce acceleration and strategic initiatives, but risks include margin pressure from promotions and flat store traffic. Valuation at a P/E of 21.09 appears reasonable given growth prospects, yet execution on new categories and macroeconomic sensitivity to consumer spending are key watchpoints for sustained upside.